SCHEMBL1124418

SCHEMBL1124418

O=C(O)C=Cc1ccc(C(F)(F)F)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.53
RAB9A P51151 4/20 0.47
CYP1A2 P05177 2/20 0.43
NPC1 O15118 2/20 0.43
KDM4E B2RXH2 3/20 0.42
LMNA P02545 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
PFKFB3 Q16875 1/20 0.41
HTT P42858 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP1A1 P04798 1/20 0.41
MAOB P27338 1/20 0.41
CYP1B1 Q16678 1/20 0.41
PTGS1 P23219 1/20 0.40
P4HTM Q9NXG6 1/20 0.40
HDAC3 O15379 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1124416 1.00 KMT2A (0.53) KMT2ARAB9ACYP1A2NPC1KDM4E
SCHEMBL1124164 0.85 KMT2A (0.56) KMT2ARAB9ACYP1A2NPC1KDM4E
SCHEMBL1124166 0.85 KMT2A (0.56) KMT2ARAB9ACYP1A2NPC1KDM4E
SCHEMBL15435161 0.78 KMT2A (0.46) KMT2ARAB9ACYP1A2NPC1KDM4E
Trifluoroacetic Acid SCHEMBL1970997 0.77 KDM4E (0.41) KMT2ARAB9AKDM4ELMNAHTT
SCHEMBL16031471 0.77 ALDH1A1 (0.44) CYP1A2KDM4ELMNACYP2C9HPGD
SCHEMBL16031469 0.77 ALDH1A1 (0.44) CYP1A2KDM4ELMNACYP2C9HPGD
Trifluoroacetic Acid SCHEMBL1970993 0.77 KDM4E (0.41) KMT2ARAB9AKDM4ELMNAHTT
SCHEMBL15397509 0.77 KDM4E (0.46) KMT2ARAB9AKDM4ELMNAHTT
SCHEMBL15397508 0.77 KDM4E (0.46) KMT2ARAB9AKDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10669268-B2 Bicyclic derivatives HOFFMANN-LA ROCHE INC. (US) 2020-06-02 US disclosed
US-20180118741-A1 NEW BICYCLIC DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2018-05-03 US disclosed
US-20170050960-A1 NEW BICYCLIC DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2017-02-23 US disclosed
US-20150353559-A1 NEW BICYCLIC DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2015-12-10 US disclosed
US-20110281869-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS AISSAOUI HAMED (FR) 2011-11-17 US disclosed
EP-2282996-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS Actelion Pharmaceuticals Ltd. (CH) 2011-02-16 EP disclosed
WO-2009141782-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS ACTELION PHARMACEUTICALS LTD (CH) 2009-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10669268-B2 Bicyclic derivatives CCNY, BICRA, UQCRB KMT2A 504/4885RAB9A 753/4885CYP1A2 22/4885
US-20170050960-A1 NEW BICYCLIC DERIVATIVES BICRA, CCNY, UQCRB KMT2A 586/4885RAB9A 710/4885CYP1A2 25/4885
US-20180118741-A1 NEW BICYCLIC DERIVATIVES BICRA, CCNY, UQCRB KMT2A 586/4885RAB9A 710/4885CYP1A2 25/4885
US-20150353559-A1 NEW BICYCLIC DERIVATIVES BICRA, CCNY, UQCRB KMT2A 586/4885RAB9A 710/4885CYP1A2 25/4885
US-20110281869-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS QTRT2, RECQL, QTRT1 KMT2A 865/4885RAB9A 856/4885CYP1A2 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.